FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Texas congressional candidate claims she never called for ‘internment camps’ after party leaders condemn her

Watch: ‘Survivor’ Host’s Awkward Blunder During Live Finale Spoils Results

Breaking: NASCAR Champion Kyle Busch Dead at Age 41

DHS touts millions of illegal immigrant departures as border crossings drop 94% under Trump

‘Botched’ lethal injection earns Tennessee death row inmate reprieve

College students accused of turning popular beach town into booze-soaked free-for-all in takeover chaos

Single Chart Shows DNC’s Downfall Among the American Electorate Since 2009

Man arrested for allegedly hurling beer keg through window of famous Georgetown Cupcake bakery

Sanders caught on camera snapping at reporter over Platner’s posts: ‘Get a better job’

Former Detroit mayor blows governor’s race wide open in surprise move

Trump Admin Moves to Supercharge Deportations with Unprecedented Immigration Judge Addition

Arts commission approves plans for Trump’s triumphal arch

NASCAR Star Kyle Busch Hospitalized with ‘Severe’ Medical Issue

Senate Republicans Deal a Serious Blow to Trump’s White House Ballroom Project

RNC legal victory clears North Carolina voter roll purge of noncitiznes through jury responses

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”